Company Overview and News

1
PRECIOUS-Gold hits 1-wk high as dollar sags on Trump's Fed attack

2h reuters
BENGALURU, Aug 22 (Reuters) - Gold prices hit a fresh one-week high on Wednesday amid ongoing weakness in the dollar following U.S. President Donald Trump’s attack on the Federal Reserve over interest rates.
2840 GLD

7
5 ETF Areas Investors Keep Away From

2018-08-20 zacks
The year 2018 has been all about an improving U.S. economy, slowdown in other developed economies, call for protectionism by President Trump, a hawkish Fed, policy tightening at a few other central banks as well as emerging market pain with Turkey being at the center point of crisis.
VGK URBN 2840 GLD

1
Gold inches higher as US-China trade optimism puts pressure on dollar

2018-08-20 thehindubusinessline
Spot gold rose 0.1 per cent to $1,185.31 an ounce at 0245 GMT. Last week, it had touched its lowest since January 2017 at $1,159.96.
2840 GLD

1
Gold Is Melting: Why This Is No Time To Panic

2018-08-17 seekingalpha
Gold has been dented in recent months, crashing by nearly 15% from peak to trough in just 4 months.
O87 GDX NASH GLD SLV

1
GLD / SPDR Gold Shares ETF OPTIONS REPORT JULY 2018

2018-08-15 sec.gov
ETF Options Report July 2018 Filed Pursuant To Rule 433 Registration No. 333-217785 August 15, 2018
GLD

1
Beware Of Physical Gold's Diminishing Value

2018-08-15 seekingalpha
Gold has been dubbed by some as the "world's friend for 5,000 years." While that may be true to varying degrees, it doesn't necessarily mean gold or precious metals have been a friendly place to invest. A recent example of gold's unfriendly string is its 28-year period of long-suffering. After gold prices peaked in nominal dollars at $850 per ounce in 1980, it wasn't until 2008 that gold was able to eventually match its 1980 peak price.
GLDM OUNZ O87 UGL GLD IAU

1
PRECIOUS-Gold prices slip to 18-month low on sturdy dollar

2018-08-15 reuters
BENGALURU, Aug 15 (Reuters) - Gold prices slipped to their lowest since January 2017 early on Wednesday, pressured as the U.S. dollar clung to its highest in 13 months.
GFI.WI GFI 2840 GFIOF GLD

1
GLD / SPDR Gold Shares ETF TRADING REPORT JULY 2018

2018-08-14 sec.gov
ETF Trading Report July 2018 Filed Pursuant To Rule 433 Registration No. 333-217785 August 14, 2018
GLD

1
PRECIOUS-Gold advances as dollar softens

2018-08-14 reuters
LONDON, Aug 14 (Reuters) - Gold rose from near 18-month lows on Tuesday, attempting a break back above the key $1,200 level as the dollar softened and analysts said the precious metal could have fallen too far.
2840 GLD

1
Gold recovers from 18-month low

2018-08-14 thehindubusinessline
Gold prices recovered from an 18-month low hit in the previous session as a break below a key psychological level triggered buying, while the US dollar pared gains after scaling a 13-month high.
2840 GLD

1
GLD / SPDR Gold Shares ETF CAPITAL MARKETS PERSPECTIVE

2018-08-13 sec.gov
ETF Capital Markets Perspective Free Writing Prospectus Filed Pursuant To Rule 433 Registration No. 333-217785 August 13, 2018
GLD

20
Money For Nothing: When Fiscal And Monetary Policy Fail Simultaneously (Part II)

2018-08-13 seekingalpha
Two massive "economic engineering” experiments were tried out during the "Great Moderation" that led to the 2006-2009 Global Financial Crisis (“GFC”), and during the Great Inflation (1965-1982).
XOM GLD FNMA FMCKI FMCKJ O87 RIG FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCC FMCCS FMCCT SGAZF

5
Thorny Returns For RBI Capital In Q2: Momentum Still Eating Shorts

2018-08-13 valuewalk
RBI Capital Partners continued to struggle during the second quarter, along with most other hedge funds looking for a top in the equities market any day now. In the RBI Capital Q2 2018 letter, Managing Member Skip Tague reported that the fund’s long/short portfolio was down 5.2% gross and 5.6% net for the quarter. The short-only RBI Capital Kodiak fund was down 8.8% gross and net for the quarter.
O87 WWE CSCO NUAN GLD

1
PRECIOUS-Gold hits 17-month low as investors seek refuge in dollar

2018-08-13 reuters
LONDON, Aug 13 (Reuters) - Gold prices sank below $1,200 per ounce for the first time in 17 months on Monday, losing out to U.S. Treasuries and a stronger dollar as investors sought refuge from a financial market rout triggered by a crashing Turkish lira.
2840 GLD

1
PRECIOUS-Gold hits 17-month low as investors seek refuge in dollar

2018-08-13 reuters
LONDON, Aug 13 (Reuters) - Gold prices hit 17-month lows on Monday, losing out to U.S. Treasuries and a stronger dollar as investors sought refuge from a financial market rout triggered by a crashing Turkish lira.
2840 GLD

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 78463V957